Search

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.

… Monday, April 1, 2024 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting

Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation.

… Wednesday, November 17, 2021 Sometimes the best way to understand a biological process is to disrupt the normal process and analyze the result. That’s why Sloan Kettering Institute (SKI) researchers used a strain of mutant mice as a means to uncover new clues about the process of meiosis, which forms

Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.

… Sunday, June 4, 2023 Breakthrough data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting press program and simultaneously published in  The New England Journal of Medicine (NEJM)  today found that vorasidenib

Read about Josh Foromera, who was born in a small village in Zimbabwe and recently began a fellowship in the Gastroenterology, Hepatology, and Nutrition Service at MSK.

… Thursday, December 3, 2020 Summary Josh Foromera was born in a small village in Zimbabwe and recently began a fellowship in the Gastroenterology, Hepatology, and Nutrition Service at MSK. On July 1, Josh Foromera moved to New York City to begin his three-year fellowship in the Gastroenterology, Hepatology

The Coalition was discussed at the fourth annual Bloomberg New Economy Forum (NEF) in Singapore on November 16–19.

… Friday, November 19, 2021 Memorial Sloan Kettering Cancer Center (MSK) has joined the Bloomberg New Economy International Cancer Coalition , a multiyear coalition to foster international clinical trial collaboration with the goal of accelerating access, development, and approvals of effective cancer prevention

For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients.

… Wednesday, October 11, 2017 Summary People with genetic mutations in genes controlling DNA repair may benefit especially well from certain targeted drugs and chemotherapies . A new study has determined how common these mutations are across cancer types. The results pave the way for more tailored cancer

The immune system is a powerful tool for fighting cancer — sometimes too powerful.

… Tuesday, March 8, 2016 Summary When patients receive immunotherapies for cancer, they sometimes experience immune-related side effects, which result from the immune system attacking healthy cells. Two new papers by MSK scientists provide insights into how the immune response can be manipulated to fight

Three Gerstner Sloan Kettering students -- Marta Kovatcheva, Isabel Lam, and Elizabeth Wasmuth -- have been awarded grants that recognize their academic and research excellence.

… Friday, March 20, 2026 Marta Kovatcheva, a second-year student, has received a Natural Sciences and Engineering Research Council (NSERC) Postgraduate Scholarship (PGS). Since the agency’s inception in 1978, these scholarships have been providing financial support to high-caliber students engaged in master

For some patients with metastatic melanoma, a combination of two immunotherapies works better than either drug alone.

… Monday, April 3, 2017 Summary New study data presented at the 2017 AACR Annual Meeting showed that for some patients with metastatic melanoma , a combination of two immunotherapies works better than either drug alone. While some patients with metastatic melanoma benefit greatly from treatment with an

MSK highlights from the recent European Society for Medical Oncology (ESMO) Congress include promising findings on new lung, pancreatic, and colorectal cancer treatments and new insights for how molecular testing can guide personalized medicine.

… Tuesday, October 21, 2025 Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented new studies related to a range of cancer types at the European Society for Medical Oncology (ESMO) Congress 2025, held October 17 to 21 in Berlin.   Highlights included the latest updates on three phase